These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2905268)

  • 21. Tonic inhibition of renal response to vasopressin by a pertussis toxin substrate.
    Jeffries WB; Fallet R; Gong GD; Van Dreal P; Pettinger WA
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1107-15. PubMed ID: 2904771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
    Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
    Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers.
    Noll T; Hempel A; Piper HM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1878-83. PubMed ID: 8945904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2-36.
    Bouali SM; Fournier A; Jolicoeur FB
    Regul Pept; 1994 Dec; 54(2-3):367-72. PubMed ID: 7716271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
    Yu XJ; Moskowitz MA
    Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of alpha 2-adrenergic inhibition on ADH action by pertussis toxin in rabbit CCT.
    Ribeiro CP; Ribeiro-Neto F; Field JB; Suki WN
    Am J Physiol; 1987 Jul; 253(1 Pt 1):C105-12. PubMed ID: 2886051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the natriuretic action of the imidazoline receptor agonist moxonidine by indometacin in the rat.
    Darkwa FK; Smyth DD
    Pharmacology; 1995 Dec; 51(6):347-55. PubMed ID: 8966191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.
    Evéquoz D; Aubert JF; Nussberger J; Biollaz J; Diezi J; Brunner HR; Waeber B
    Nephron; 1996; 73(3):467-72. PubMed ID: 8832609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
    Intengan HD; Smyth DD
    Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of clonidine on the kidney function in the anesthetized dog.
    Kövér G; Tost H; Darvasi A
    Acta Physiol Hung; 1989; 74(3-4):229-41. PubMed ID: 2640405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressed renal response to 2,6-dimethyl clonidine but not clonidine in one kidney-one clip hypertensive rats.
    Li P; Smyth DD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1395-400. PubMed ID: 7903388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.
    Blasquez C; Jégou S; Tranchand Bunel D; Fournier A; Vaudry H
    Brain Res; 1992 Nov; 596(1-2):163-8. PubMed ID: 1334775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertussis toxin treatment.
    Colmers WF; Pittman QJ
    Brain Res; 1989 Sep; 498(1):99-104. PubMed ID: 2507090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons.
    Aghajanian GK; Wang YY
    Brain Res; 1986 Apr; 371(2):390-4. PubMed ID: 3697768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between neuropeptide Y and alpha 2-adrenoceptors in selective rat brain regions.
    Widdowson PS; Masten T; Halaris AE
    Peptides; 1991; 12(1):71-5. PubMed ID: 1647005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of neuropeptide Y (NPY) in ventricular cardiomyocytes.
    Millar BC; McDermott BJ; Piper HM; Balasubramaniam A; Weis T
    Adv Exp Med Biol; 1992; 311():325-6. PubMed ID: 1529762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
    Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
    Mol Pharmacol; 2000 Jun; 57(6):1142-51. PubMed ID: 10825384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13-36) in the awake unrestrained male rat.
    Narváez JA; Aguirre JA; Van der Ploeg I; Fuxe K
    Neurosci Lett; 1992 Jun; 140(2):273-6. PubMed ID: 1386917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.